Carriers of HLA-B*15:02 can solely develop severe SJS/TEN, whereas HLA-A*31:01-carriers show a wider area of symptoms including MPE or DRESS [38,40,47]. This evidence concerns the gene HLA-A and toxic epidermal necrolysis.